Viewpoint discusses air travel safety in thoracic aortic disease, suggesting a risk-based approach for clinicians.
Patients with thoracic aortic disease (TAD) frequently seek advice on the safety of commercial air travel. Despite the clinical relevance of this question, robust evidence is virtually absent, and current recommendations rely largely on expert opinion. This Viewpoint discusses the physiological effects of flights, reviews the limited available evidence, and proposes a pragmatic, risk-based approach for clinicians counselling patients with TAD.
No takes yet. Share an insight, caveat, or question.
Grewal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: